Friday, April 18

AI

AI: Accelerating Commercialization Strategies for Advanced Therapies
AI

AI: Accelerating Commercialization Strategies for Advanced Therapies

AI Can Help Accelerate Commercialization Strategies Main Ideas: Decision support in process development is crucial for advanced therapies. Artificial intelligence (AI) can enable robust manufacturing and help bring new drugs to the market. Advanced therapies have fewer established processes and complex product development. AI can fill the gap in background knowledge for these new drugs. Author's Take: Artificial intelligence is becoming a valuable tool in the commercialization of advanced therapies. With the complexity and lack of established processes in these new drugs, AI can provide decision support and help ensure robust manufacturing. By filling the knowledge gap, AI has the potential to accelerate the development and commercialization of these innovative treatments. Click here for...
US National Science Foundation and NVIDIA Launch AI Research Program: Fostering Responsible AI Innovation
AI

US National Science Foundation and NVIDIA Launch AI Research Program: Fostering Responsible AI Innovation

U.S. National Science Foundation and NVIDIA launch AI research program Main ideas: The U.S. National Science Foundation (NSF) has introduced the National Artificial Intelligence Research Resource pilot program. NVIDIA is partnering with NSF to support the initiative. The program aims to enhance access to the necessary resources for responsible AI research and development. The launch of the program signifies a step forward in building a shared national research infrastructure. Author's take: The collaboration between the U.S. National Science Foundation and NVIDIA in launching the National Artificial Intelligence Research Resource pilot program is a significant development in fostering responsible AI discovery and innovation. By broadening access to key tools, this initiative is expected ...
Llama 2 Inference and Fine-Tuning Now on AWS Trainium and Inferentia Instances: Reduce Costs and Latency
AI

Llama 2 Inference and Fine-Tuning Now on AWS Trainium and Inferentia Instances: Reduce Costs and Latency

Llama 2 Inference and Fine-Tuning Support Now Available on AWS Trainium and AWS Inferentia Instances in Amazon SageMaker JumpStart Main Ideas: Llama 2 inference and fine-tuning support is now accessible on AWS Trainium and AWS Inferentia instances in Amazon SageMaker JumpStart. Using AWS Trainium and Inferentia based instances can reduce fine-tuning costs by up to 50% and deployment costs by 4.7 times. The technology helps in decreasing per token latency. Author's Take: The availability of Llama 2 inference and fine-tuning support on AWS Trainium and AWS Inferentia instances in Amazon SageMaker JumpStart brings cost and performance benefits to users by reducing fine-tuning and deployment costs while decreasing latency. This further strengthens AWS's position as a leading provider of AI i...